X0202 SCHEDULE 13G/A 0001212897 XXXXXXXX LIVE 2 Common Stock, $0.001 par value per share 09/30/2026 0001561921 TELA Bio, Inc. 872381108 1 Great Valley Parkway Suite 24 Malvern PA 19355 Rule 13d-1(c) North Run Capital, LP b DE 0 3528296 0 3528296 3528296 N 7.8 PN North Run Advisors, LLC b DE 0 3528296 0 3528296 3528296 N 7.8 OO North Run - Due North Partners, LP b DE 0 3528296 0 3528296 3528296 N 7.8 PN North Run GP, LP b DE 0 3528296 0 3528296 3528296 N 7.8 PN Todd B. Hammer b X1 0 3528296 0 3528296 3528296 N 7.8 IN Thomas B. Ellis b X1 0 3528296 0 3528296 3528296 N 7.8 IN Michael Bosco b X1 0 3528296 0 3528296 3528296 N 7.8 IN TELA Bio, Inc. 1 Great Valley Parkway, Suite 24, Malvern, PA 19355 This Schedule 13G is being filed on behalf of North Run Capital, LP, a Delaware limited partnership (the "Investment Manager"), North Run Advisors, LLC, a Delaware limited liability company ("North Run"), North Run - Due North Partners, LP, a Delaware limited partnership ("Due North"), North Run GP, LP, a Delaware limited partnership (the "GP"), Todd B. Hammer, Thomas B. Ellis and Michael Bosco (collectively, the "Reporting Persons").The Investment Manager is the investment manager of certain private pooled investment vehicles, including Due North. Todd B. Hammer, Thomas B. Ellis and Michael Bosco are the limited partners of Due North. This Schedule 13G relates to shares of Common Stock, par value $0.001 per share (the "Common Stock"), of TELA Bio, Inc., a Delaware corporation (the "Issuer"), held by the Due North. For all Filers: 867 Boylston St., 5th Floor #1361, Boston, MA 02116. (1) North Run Capital, LP is a Delaware limited partnership. (2) North Run Advisors, LLC is a Delaware limited liability company. (3) North Run - Due North Partners, LP is a Delaware limited partnership. (4) North Run GP, LP is a Delaware limited partnership. (5) Todd B. Hammer is a U.S. citizen. (6) Thomas B. Ellis is a U.S. citizen. (7) Michael Bosco is a U.S. citizen. Y The Investment Manager, North Run, Todd B. Hammer, Thomas B. Ellis, Michael Bosco, Due North and the GP may be deemed the beneficial owners of 3,528,296 shares of Common Stock as of September 30, 2026. The Investment Manager, North Run, Todd B. Hammer, Thomas B. Ellis, Michael Bosco, Due North and the GP may be deemed the beneficial owners of approximately 7.8% of the outstanding shares of Common Stock as of September 30, 2026. The percent of class is based upon 45,143,410 shares of Common Stock outstanding as of September 1, 2026, as reported in the Issuer's proxy statement filed with the Securities and Exchange Commission on September 14, 2026. Not applicable. The Investment Manager, North Run, Todd B. Hammer, Thomas B. Ellis, Michael Bosco, Due North and the GP have the shared power to vote the 3,528,296 shares of Common Stock beneficially owned as of September 30, 2026. Not applicable. The Investment Manager, North Run, Todd B. Hammer, Thomas B. Ellis, Michael Bosco, Due North and the GP have the shared power to dispose of the 3,528,296 shares of Common Stock beneficially owned as of September 30, 2026. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. North Run Capital, LP /s/ Michael Fisher 11/13/2026 North Run Advisors, LLC /s/ Michael Fisher 11/13/2026 North Run - Due North Partners, LP /s/ Michael Fisher 11/13/2026 North Run GP, LP /s/ Michael Fisher 11/13/2026 Todd B. Hammer /s/ Michael Fisher 11/13/2026 Thomas B. Ellis /s/ Michael Fisher 11/13/2026 Michael Bosco /s/ Michael Fisher 11/13/2026